Analyze Diet
Domestic animal endocrinology2023; 83; 106785; doi: 10.1016/j.domaniend.2023.106785

Short Communication: Identification of equine corticotropin-like intermediate lobe peptide (CLIP) binding to an adrenocortipcotrophic hormone (ACTH) assay capture antibody.

Abstract: A chemiluminescent immunoassay is commonly employed to measure adrenocorticotrophic hormone (ACTH) concentrations to assist pituitary pars intermedia dysfunction diagnosis. In a previous study, seasonally-dependent assay cross-reactivity to endogenous equine corticotropin-like intermediate lobe peptide (CLIP, ACTH 18-39) was suspected. The present study aimed to demonstrate binding of endogenous equine CLIP to the capture antibody of the ACTH chemiluminescent immunoassay. Liquid chromatography - mass spectrometry (LCMS) methods were optimised to identify selected ions from synthetic human ACTH, α-melanocyte stimulating hormone (α-MSH, ACTH 1-17) and CLIP. Synthetic ACTH and CLIP bound to the capture antibody of the chemiluminescent ACTH assay, but α-MSH did not. Equine endogenous CLIP was detected by LCMS in pony plasma taken in the autumn and could be eluted from the capture antibody of the ACTH chemiluminescent immunoassay. Further research is required to enable quantification of CLIP. Equine CLIP may alter measured ACTH concentrations in vivo.
Publication Date: 2023-01-16 PubMed ID: 36745973DOI: 10.1016/j.domaniend.2023.106785Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article focuses on the exploration of adrenocorticotrophic hormone (ACTH) concentration measurement methods that aid in diagnosing pituitary pars intermedia dysfunction in horses. The study specifically evaluates how the hormone equine corticotropin-like intermediate lobe peptide (CLIP) interacts with the commonly used chemiluminescent immunoassay.

Background

  • ACTH is a hormone produced and released by the pituitary gland, playing a critical role in the stress response and regulation of blood cortisol levels.
  • In horses, accurate measurement of ACTH concentration is essential in diagnosing pituitary pars intermedia dysfunction, a common equine endocrine disorder.
  • The diagnosis process typically uses a chemiluminescent immunoassay, a test that measures specific proteins in the blood.
  • A previous study suggested that ACTH measurements might be seasonally influenced by the cross-reactivity of the immunoassay with endogenous equine CLIP, a portion of the ACTH molecule.

Aim of the Study

  • This research aimed to demonstrate if and how the endogenous equine CLIP binds to the capture antibody in the ACTH chemiluminescent immunoassay.

Methodology

  • The research used liquid chromatography-mass spectrometry (LCMS) methods to identify specific ions from synthetic versions of human ACTH, α-melanocyte-stimulating hormone (α-MSH), and CLIP.
  • These synthetic molecules were then tested to assess their binding to the capture antibody in the ACTH chemiluminescent immunoassay.
  • Furthermore, the research studied plasma samples from ponies taken in autumn to evaluate the occurrence and interaction of endogenous equine CLIP with the immunoassay.

Findings

  • The study found that synthetic ACTH and CLIP bind to the capture antibody of the chemiluminescent ACTH immunoassay, but α-MSH does not.
  • Moreover, endogenous equine CLIP was identified in the pony plasma collected in autumn, and it could be eluted from the assay’s capture antibody.

Conclusion and Further Research

  • The findings suggested that equine CLIP may influence the measured ACTH concentrations in vivo, potentially affecting the accuracy of pituitary pars intermedia dysfunction diagnosis.
  • However, the study concluded that more research is needed to quantify CLIP and further evaluate its impact on ACTH measurements in the diagnosis process.

Cite This Article

APA
Knowles EJ, Hyde C, Harris PA, Elliott J, Menzies-Gow NJ. (2023). Short Communication: Identification of equine corticotropin-like intermediate lobe peptide (CLIP) binding to an adrenocortipcotrophic hormone (ACTH) assay capture antibody. Domest Anim Endocrinol, 83, 106785. https://doi.org/10.1016/j.domaniend.2023.106785

Publication

ISSN: 1879-0054
NlmUniqueID: 8505191
Country: United States
Language: English
Volume: 83
Pages: 106785
PII: S0739-7240(23)00001-2

Researcher Affiliations

Knowles, E J
  • Department of Clinical Science and Services, The Royal Veterinary College, Hawkshead Lane, Hatfield, Herts AL9 7TA, UK; Bell Equine Veterinary Clinic, Mereworth, ME18 5GS UK. Electronic address: ejknowles@rvc.ac.uk.
Hyde, C
  • Bio-Analysis Centre, 2 Royal College St, London NW1 0NH, UK.
Harris, P A
  • Waltham Petcare Science Institute, Waltham on the Wold, LE14 4RT, Leicester, UK.
Elliott, J
  • Department of Comparative Biomedical Sciences, The Royal Veterinary College, Royal College Street, London, NW1 0TU, UK.
Menzies-Gow, N J
  • Department of Clinical Science and Services, The Royal Veterinary College, Hawkshead Lane, Hatfield, Herts AL9 7TA, UK.

MeSH Terms

  • Horses
  • Animals
  • Humans
  • Corticotropin-Like Intermediate Lobe Peptide / metabolism
  • alpha-MSH / metabolism
  • Adrenocorticotropic Hormone
  • Antibodies
  • Pituitary Gland / metabolism
  • Melanocyte-Stimulating Hormones / metabolism

Citations

This article has been cited 0 times.